Literature DB >> 24350023

Progressive symmetric erythrokeratoderma with nephrotic syndrome: Coincidence or new association?

S Sacchidanand1, M S Sahana1, Sushruth G Kamoji1, G S Asha1.   

Abstract

Progressive symmetric erythrokeratoderma (PSEK) is a rare genodermatosis with variable inheritance. It is characterized by symmetrical, erythematous, and hyperkeratotic plaques on the extremities. We report a case of a 15-year-old boy with PSEK of autosomal recessive inheritance associated with nephrotic syndrome.

Entities:  

Keywords:  Erythrokeratoderma; nephrotic syndrome; symmetric

Year:  2013        PMID: 24350023      PMCID: PMC3853908          DOI: 10.4103/2229-5178.120680

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN: 2229-5178


INTRODUCTION

Progressive symmetric erythrokeratoderma (PSEK) or Gottron's syndrome is a rare genodermatosis with variable inheritance, but mostly follows an autosomal dominant pattern.[1] It is characterized by stable, well-demarcated, symmetric hyperkeratotic plaques. Approximately 40 cases have been described in literature. There are few case reports of association of PSEK with other disorders. We report a rare case of PSEK associated with nephrotic syndrome.

CASE REPORT

A15-year-old boy born of second-degree consanguineous marriage presented with asymptomatic scaly skin lesions on the extremities since 5 years. Lesions initially started on dorsum of feet, and gradually progressed to involve knees and hands. These lesions were persistent and nonmigratory. There was no history of similar skin eruptions in the family or siblings. He had steroid-dependent nephrotic syndrome from infancy. Cutaneous examination showed well-demarcated, hyperpigmented, hyperkeratotic scaly plaques distributed symmetrically on the dorsum of hands and feet, elbows, knees, and tendoachillies [Figures 1–3]. Palms and soles were normal. There was no abnormality of hair, nails, or mucous membrane. There was no musculoskeletal or ocular abnormality. He had puffiness of face with cushingoid features and pedal edema. Skin biopsy revealed hyperkeratosis, focal parakeratoses, acanthosis, normal granular layer, and a moderate mononuclear infiltration in upper dermis [Figure 4]. Based on clinical and histopathological findings, diagnosis of PSEK was made. He was treated with emollients, topical steroids, and keratolytics with marked improvement.
Figure 1

Well-demarcated hyperkeratotic plaques on dorsum of hands

Figure 3

Well-demarcated symmetrical hyperpigmented, hyperkeratotic plaques on knee joint and dorsum of feet

Figure 4

Moderate acanthosis, hyperkeratosis, focal parakeratosis, and mild superficial perivascular dermal lymphocytic infiltrate (H and E, ×400)

Well-demarcated hyperkeratotic plaques on dorsum of hands Well-demarcated symmetrical hyperkeratotic plaques on dorsum of feet and lower legs Well-demarcated symmetrical hyperpigmented, hyperkeratotic plaques on knee joint and dorsum of feet Moderate acanthosis, hyperkeratosis, focal parakeratosis, and mild superficial perivascular dermal lymphocytic infiltrate (H and E, ×400)

DISCUSSION

Erythrokeratodermas are rare genodermatosis inherited as autosomal dominant disorders, although autosomal recessive transmission has been observed with high penetrance but marked intra- and interfamilial variability of expression. Erythrokeratodermas have been divided into two major non-syndromic types and some syndromes such as KID (keratitis, ichthyosis, deafness) syndrome and HID (hystrix like, ichthyosis, deafness) syndrome.[2] The two major non-syndromic types have been described as PSEK and erythrokeratoderma variabilis (EKV).[3] It was first described by Darier in 1911 as “progressive and symmetrical verrucous erythrokeratoderma.” Gottron shortened the name of this condition to “symmetrical progressive erythrokeratoderma.”[4] PSEK is heterogeneous with considerable phenotypic variability. Although some cases have been identified to have loricrin and few to have connexin mutations in PSEK, EKV, or both, recent reports show that the same gene mutations were not found in some pedigree of PSEK.[5] PSEK usually appears in infancy or childhood, and shows an equal sex incidence. Skin lesions are characterized by fixed, large, well-defined hyperkeratotic plaques, or reddish orange to brownish color with marked erythema at their periphery. They are symmetrically distributed. Lesions commonly occur on limbs, buttocks, shoulders, and fingers, and may involve the face.[6] There is marked tendency for improvement after puberty, but may persist into adulthood. An erythematous palmoplantar keratoderma is seen in about 50% of patients.[6] PSEK has to be differentiated from pityriasis rubra pilaris, psoriasis, and other types of erythrokeratoderma, especially EKV. It differs from EKV in the absence of migratory erythematous lesions and in greater incidence of palmoplantar keratoderma. The symmetry of the lesions in PSEK is more striking than in EKV.[6] Two sisters have been described, among whom the younger one suffered from EKV whereas the older one suffered from PSEK, and this report brought forward the hypothesis that PSEK and EKV were different manifestations of a single condition.[7] The histopathology is nonspecific and shows hyperkeratosis with patchy parakeratoses overlying an acanthotic epidermis with intact granular layer.[6] Various reports are published in literature regarding association of PSEK with high-arched palate, fissured tongue, pectus excavatum, symmetric syndactylism, and keratosis pilaris.[89] Recently PSEK associated with delayed intellectual milestones and convulsions has been reported.[10] In our case, PSEK was associated with nephrotic syndrome. Topical emollients, keratolytics, and topical steroids have limited benefit, but oral retinoid therapy may result in improvement.[11] There was marked improvement with topical steroids and keratolytics in our case. It is not known whether there is underlying genetic cause for association of PSEK with nephrotic syndrome or it is just a coincidence. This case is interesting not only for its rarity but also for its rare association with nephrotic syndrome, which is not described in literature earlier and hence reported.
  9 in total

1.  Symmetrical progressive erythro-keratoderma.

Authors:  G Sunil; K Usha
Journal:  Indian J Dermatol Venereol Leprol       Date:  1999 Jul-Aug       Impact factor: 2.545

2.  Gottron's syndrome.

Authors:  N S Walia; R Raj; C S Tak
Journal:  Indian J Dermatol Venereol Leprol       Date:  2001 Jul-Aug       Impact factor: 2.545

3.  Progressive symmetric erythrokeratoderma: report of a Chinese family.

Authors:  Hong-Bo Yan; Jing Zhang; Wen Liang; Hang-Yang Zhang; Jing-Yu Liu
Journal:  Indian J Dermatol Venereol Leprol       Date:  2011 Sep-Oct       Impact factor: 2.545

4.  A novel connexin 26 mutation in a patient diagnosed with keratitis-ichthyosis-deafness syndrome.

Authors:  Maurice A M van Steensel; Michel van Geel; Marc Nahuys; J Henk Sillevis Smitt; Peter M Steijlen
Journal:  J Invest Dermatol       Date:  2002-04       Impact factor: 8.551

5.  Erythrokeratodermia progressiva symmetrica: report of 10 cases.

Authors:  R Ruiz-Maldonado; L Tamayo; V del Castillo; I Lozoya
Journal:  Dermatologica       Date:  1982-02

Review 6.  Acitretin in the treatment of erythrokeratodermia variabilis.

Authors:  P C van de Kerkhof; P M Steijlen; R J van Dooren-Greebe; R Happle
Journal:  Dermatologica       Date:  1990

7.  Progressive symmetric erythro-keratosis associated with oligodontia, severe caries, disturbed hair growth and ectopic nail: a new syndrome?

Authors:  Maria Rita Bongiorno; Mario Aricò
Journal:  Dermatology       Date:  2008-09-18       Impact factor: 5.366

8.  Is erythrokeratoderma one disorder? A clinical and ultrastructural study of two siblings.

Authors:  A W Macfarlane; S J Chapman; J L Verbov
Journal:  Br J Dermatol       Date:  1991-05       Impact factor: 9.302

9.  Progressive symmetric erythrokeratodermia with delayed intellectual milestones and convulsions.

Authors:  Shyam B Verma; Uwe Wollina
Journal:  Indian Dermatol Online J       Date:  2012-01
  9 in total
  3 in total

1.  Progressive symmetrical erythrokeratoderma on the face: A rare condition and successful treatment with calcipotriol.

Authors:  Nagihan Tarikci; Emek Kocatürk Göncü; Tülin Yüksel; Ralfi Singer; İlteriş Oğuz Topal; İlknur Mansuroğlu Şahin
Journal:  JAAD Case Rep       Date:  2016-02-04

2.  Progressive Symmetric Erythrokeratodermia with Overlying Psoriasis as Wolf's Isotopic Phenomenon: A Case Report.

Authors:  Ghazal Ahmed; Satyaki Ganguly; Ritul Choudhary; C Anju George
Journal:  Indian Dermatol Online J       Date:  2022-03-03

3.  Late Onset Progressive Symmetric Erythrokeratoderma with Pseudo Ainhum.

Authors:  Gowrappala Shanmukhappa Asha; Dammaningala Venkataramaiah Lakshmi; Kanathur Shilpa; Gorur Kallappa Divya
Journal:  Indian J Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.